Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

Clinical Trial ID NCT00077467

PubWeight™ 2.88‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00077467

Top papers

Rank Title Journal Year PubWeight™‹?›
1 NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 2010 1.25
2 Novel agents for the treatment of childhood acute leukemia. Ther Adv Hematol 2015 0.87
3 Advances in paediatric cancer treatment. Transl Pediatr 2014 0.76
Next 100